<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Rev Bras Ter Intensiva</journal-id><journal-id journal-id-type="iso-abbrev">Rev Bras Ter Intensiva</journal-id><journal-id journal-id-type="publisher-id">rbti</journal-id><journal-title-group><journal-title>Revista Brasileira de Terapia Intensiva</journal-title></journal-title-group><issn pub-type="ppub">0103-507X</issn><issn pub-type="epub">1982-4335</issn><publisher><publisher-name>Associa&#x000e7;&#x000e3;o de Medicina Intensiva Brasileira -
AMIB</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28099643</article-id><article-id pub-id-type="pmc">5225922</article-id><article-id pub-id-type="doi">10.5935/0103-507X.20160079</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Articles</subject></subj-group></article-categories><title-group><article-title>Balanced crystalloids for septic shock resuscitation</article-title><trans-title-group xml:lang="pt"><trans-title>Cristaloides balanceados para ressuscita&#x000e7;&#x000e3;o do choque
s&#x000e9;ptico</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>Corr&#x000ea;a</surname><given-names>Thiago Domingos</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/></contrib><contrib contrib-type="author"><name><surname>Cavalcanti</surname><given-names>Alexandre Biasi</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>de Assun&#x000e7;&#x000e3;o</surname><given-names>Murillo Santucci Cesar</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Intensive Care Unit, Hospital Israelita Albert Einstein -
S&#x000e3;o Paulo (SP), Brazil.</aff><aff id="aff2"><label>2</label>Research Institute, Hospital do Cora&#x000e7;&#x000e3;o -
S&#x000e3;o Paulo (SP), Brazil.</aff><author-notes><corresp id="c1"><bold>Corresponding author:</bold> Thiago Domingos Corr&#x000ea;a,
Unidade de Terapia Intensiva, Hospital Israelita Albert Einstein, Av. Albert
Einstein, 627/701, Zip code: 05651-901 - S&#x000e3;o Paulo (SP), Brasil. E-mail:
<email>thiago.correa@einstein.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Oct-Dec</season><year>2016</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Oct-Dec</season><year>2016</year></pub-date><volume>28</volume><issue>4</issue><fpage>463</fpage><lpage>471</lpage><history><date date-type="received"><day>22</day><month>6</month><year>2016</year></date><date date-type="accepted"><day>08</day><month>8</month><year>2016</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is
properly cited.</license-p></license></permissions><abstract><p>Timely fluid administration is crucial to maintain tissue perfusion in septic
shock patients. However, the question concerning which fluid should be used for
septic shock resuscitation remains a matter of debate. A growing body of
evidence suggests that the type, amount and timing of fluid administration
during the course of sepsis may affect patient outcomes. Crystalloids have been
recommended as the first-line fluids for septic shock resuscitation.
Nevertheless, given the inconclusive nature of the available literature, no
definitive recommendations about the most appropriate crystalloid solution can
be made. Resuscitation of septic and non-septic critically ill patients with
unbalanced crystalloids, mainly 0.9% saline, has been associated with a higher
incidence of acid-base balance and electrolyte disorders and might be associated
with a higher incidence of acute kidney injury. This can result in greater
demand for renal replacement therapy and increased mortality. Balanced
crystalloids have been proposed as an alternative to unbalanced solutions in
order to mitigate their detrimental effects. Nevertheless, the safety and
effectiveness of balanced crystalloids for septic shock resuscitation need to be
further addressed in a well-designed, multicenter, pragmatic, randomized
controlled trial.</p></abstract><trans-abstract xml:lang="pt"><p>A administra&#x000e7;&#x000e3;o de fluidos em tempo adequado &#x000e9; crucial para
a manuten&#x000e7;&#x000e3;o da perfus&#x000e3;o tissular nos pacientes com choque
s&#x000e9;ptico. Entretanto, a quest&#x000e3;o da escolha do fluido a ser
utilizado para ressuscita&#x000e7;&#x000e3;o no choque s&#x000e9;ptico ainda
&#x000e9; um assunto em debate. &#x000c9; crescente o corpo de evid&#x000ea;ncia
que sugere que o tipo, a quantidade e o momento da administra&#x000e7;&#x000e3;o
de fluidos durante a evolu&#x000e7;&#x000e3;o da sepse podem afetar os desfechos
do paciente. Os cristaloides t&#x000ea;m sido recomendados como fluidos a serem
administrados em primeira linha na ressuscita&#x000e7;&#x000e3;o do choque. No
entanto, &#x000e0; luz da natureza inconclusiva da literatura dispon&#x000ed;vel,
n&#x000e3;o se podem fazer recomenda&#x000e7;&#x000f5;es definitivas quanto
&#x000e0; solu&#x000e7;&#x000e3;o cristaloide mais apropriada. A
ressuscita&#x000e7;&#x000e3;o de pacientes cr&#x000ed;ticos s&#x000e9;pticos e
n&#x000e3;o s&#x000e9;pticos com cristaloides n&#x000e3;o balanceados,
principalmente a solu&#x000e7;&#x000e3;o salina a 0,9%, tem sido associada a uma
maior incid&#x000ea;ncia de desordens do equil&#x000ed;brio &#x000e1;cido-base e a
dist&#x000fa;rbios eletrol&#x000ed;ticos, al&#x000e9;m de poder se associar
&#x000e0; maior incid&#x000ea;ncia de les&#x000e3;o renal aguda, &#x000e0; maior
necessidade de terapia de substitui&#x000e7;&#x000e3;o renal e &#x000e0;
mortalidade. Foi proposto o uso de solu&#x000e7;&#x000f5;es cristaloides
balanceadas como uma alternativa &#x000e0;s solu&#x000e7;&#x000f5;es de
cristaloides n&#x000e3;o balanceados, para mitigar seus efeitos
delet&#x000e9;rios. Entretanto, a seguran&#x000e7;a e a efic&#x000e1;cia dos
cristaloides balanceados para ressuscita&#x000e7;&#x000e3;o do choque
s&#x000e9;ptico necessitam ser mais bem exploradas em estudos cl&#x000ed;nicos bem
delineados, randomizados e controlados, multic&#x000ea;ntricos e
pragm&#x000e1;ticos.</p></trans-abstract><kwd-group><kwd>Fluid therapy/methods</kwd><kwd>Isotonic solutions/administration &#x00026; dosage</kwd><kwd>Rehydration solutions/administration &#x00026; dosage</kwd><kwd>Shock, septic</kwd><kwd>Resuscitation/methods</kwd><kwd>Critical care/methods</kwd><kwd>Critical care/trends</kwd></kwd-group><kwd-group><kwd>Hidrata&#x000e7;&#x000e3;o/m&#x000e9;todos</kwd><kwd>Solu&#x000e7;&#x000f5;es isot&#x000f4;nicas/administra&#x000e7;&#x000e3;o &#x00026;
dosagem</kwd><kwd>Solu&#x000e7;&#x000f5;es para
reidrata&#x000e7;&#x000e3;o/administra&#x000e7;&#x000e3;o &#x00026; dosagem</kwd><kwd>Choque s&#x000e9;ptico</kwd><kwd>Ressuscita&#x000e7;&#x000e3;o/m&#x000e9;todos</kwd><kwd>Cuidados cr&#x000ed;ticos/m&#x000e9;todos</kwd><kwd>Cuidados cr&#x000ed;ticos/tend&#x000ea;ncias</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>INTRODUCTION</title><p>Septic shock is characterized by intense systemic vasodilation with varying degrees
of hypovolemia.<sup>(<xref rid="r1" ref-type="bibr">1</xref>)</sup> Timely fluid
administration is crucial to improve cardiac output, restore oxygen delivery and
reverse tissue hypoxia.<sup>(<xref rid="r1" ref-type="bibr">1</xref>)</sup> As a
result, cellular and mitochondrial dysfunction as well as progression to multiple
organ dysfunction syndrome secondary to systemic inflammation and tissue
hypoperfusion are mitigated.<sup>(<xref rid="r1" ref-type="bibr">1</xref>)</sup>
Therefore, fluid administration is recommended as a first-line intervention to
resuscitate septic shock patients.<sup>(<xref rid="r2" ref-type="bibr">2</xref>)</sup></p><p>A growing body of evidence suggests that the type, amount and timing of fluid
administration during the course of sepsis may affect patient outcomes.<sup>(<xref rid="r3" ref-type="bibr">3</xref>)</sup> While early fluid administration
has been associated with decreased in-hospital mortality,<sup>(<xref rid="r4" ref-type="bibr">4</xref>)</sup> delayed resuscitation has been associated with a
pronounced release of inflammatory mediators and decreased skeletal muscle adenosine
triphosphate content and mitochondrial dysfunction.<sup>(<xref rid="r5" ref-type="bibr">5</xref>)</sup> Furthermore, liberal fluid administration to septic
shock patients yields a net positive fluid balance, which may contribute to organ
failure and poor outcomes.<sup>(<xref rid="r6" ref-type="bibr">6</xref>)</sup></p><p>Many types of fluids are available for clinicians at the bedside.<sup>(<xref rid="r3" ref-type="bibr">3</xref>)</sup> Nevertheless, since the type and
amount of administered fluids affect patient-centered outcomes,<sup>(<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r8" ref-type="bibr">8</xref>)</sup> such drugs should be prescribed with caution.<sup>(<xref rid="r3" ref-type="bibr">3</xref>)</sup> Moreover, it is important to
emphasize that fluid administration should be indicated only for those who have
impaired tissue perfusion and are deemed fluid responsive (i.e., patients with a
high likelihood of improving cardiac output after fluid administration).<sup>(<xref rid="r9" ref-type="bibr">9</xref>)</sup> Whenever fluids are judged
necessary, clear endpoints of efficacy and safety must be defined in advance in
order to maximize the efficacy of the fluids administered and minimize their
potential detrimental effects.<sup>(<xref rid="r9" ref-type="bibr">9</xref>)</sup></p><p>The question concerning which fluid should be used during septic shock resuscitation
remains a matter of debate.<sup>(<xref rid="r10" ref-type="bibr">10</xref>)</sup>
The current Surviving Sepsis Campaign Guidelines recommend crystalloids as
first-line fluids for septic shock resuscitation.<sup>(<xref rid="r2" ref-type="bibr">2</xref>)</sup> Nevertheless, no consensus has been reached
regarding which crystalloid, i.e., unbalanced or balanced, is the most appropriate
in this context.<sup>(<xref rid="r11" ref-type="bibr">11</xref>)</sup></p><p>This narrative review briefly discusses the main physicochemical properties of
unbalanced and balanced crystalloids as well as their main advantages and drawbacks.
It also presents evidence supporting balanced crystalloids as the fluids of choice
for septic shock resuscitation.</p><p>This narrative literature review includes articles published in the MEDLINE/PubMed
database until March 2016 that addressed crystalloid fluid resuscitation in
critically ill patients. We used the search term "balanced solution" and search
filters for systematic reviews (systematic [sb]) and randomized trials
(((clinical[Title/Abstract] AND trial[Title/Abstract]) OR clinical trials as
topic[MeSH Terms] OR clinical trial[Publication Type] OR random*[Title/Abstract] OR
random allocation[MeSH Terms] OR therapeutic use[MeSH Subheading])).<sup>(<xref rid="r12" ref-type="bibr">12</xref>)</sup> The search retrieved 433
references. After title and abstract screening, we selected the full-text versions
of 95 relevant citations for a thorough analysis. We also searched reference lists
of the retrieved manuscripts to identify other relevant studies.</p></sec><sec><title>CRYSTALLOIDS</title><p>Solutions containing water and freely permeable ions, mainly sodium and chloride, are
classified as crystalloids (<xref ref-type="table" rid="t1">Table
1</xref>).<sup>(<xref rid="r3" ref-type="bibr">3</xref>)</sup> Some of these
solutions have other ions, such as potassium, calcium or magnesium, and may have
buffers, most commonly bicarbonate, lactate, acetate or gluconate, to maintain
electroneutrality (balance between positive and negative ions).<sup>(<xref rid="r3" ref-type="bibr">3</xref>)</sup> Crystalloid solutions may be
hypotonic, isotonic or hypertonic in relation to human plasma.<sup>(<xref rid="r3" ref-type="bibr">3</xref>)</sup> A crystalloid solution is
considered balanced when it has a strong ion difference (SID) close to
24mEq/L,<sup>(<xref rid="r13" ref-type="bibr">13</xref>)</sup> which can be
achieved by replacing varying amounts of chloride from 0.9% saline with bicarbonate,
lactate or acetate (<xref ref-type="table" rid="t1">Table 1</xref>).<sup>(<xref rid="r3" ref-type="bibr">3</xref>)</sup></p><table-wrap id="t1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Composition of the available unbalanced and balanced crystalloids</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/><col width="12%" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Composition/properties</th><th align="center" colspan="7" rowspan="1">Solutions</th></tr><tr><th align="center" rowspan="1" colspan="1">Human plasma</th><th align="center" rowspan="1" colspan="1">0.9% saline</th><th align="center" rowspan="1" colspan="1">Ringer&#x02019;s solution</th><th align="center" rowspan="1" colspan="1">Hartmann&#x02019;s solution</th><th align="center" rowspan="1" colspan="1">Ringer&#x02019;s lactate</th><th align="center" rowspan="1" colspan="1">Ringer&#x02019;s acetate</th><th align="center" rowspan="1" colspan="1">Plasma-Lyte</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">pH</td><td align="center" rowspan="1" colspan="1">7.35 - 7.45</td><td align="center" rowspan="1" colspan="1">5.5</td><td align="center" rowspan="1" colspan="1">6.0</td><td align="center" rowspan="1" colspan="1">6.5</td><td align="center" rowspan="1" colspan="1">6.5</td><td align="center" rowspan="1" colspan="1">6.7</td><td align="center" rowspan="1" colspan="1">7.4</td></tr><tr><td align="left" rowspan="1" colspan="1">Osmolality (mOsm/L)</td><td align="center" rowspan="1" colspan="1">291</td><td align="center" rowspan="1" colspan="1">308</td><td align="center" rowspan="1" colspan="1">310</td><td align="center" rowspan="1" colspan="1">279</td><td align="center" rowspan="1" colspan="1">273</td><td align="center" rowspan="1" colspan="1">270</td><td align="center" rowspan="1" colspan="1">294</td></tr><tr><td align="left" rowspan="1" colspan="1">Sodium (mmol/L)</td><td align="center" rowspan="1" colspan="1">135 - 145</td><td align="center" rowspan="1" colspan="1">154</td><td align="center" rowspan="1" colspan="1">147</td><td align="center" rowspan="1" colspan="1">131</td><td align="center" rowspan="1" colspan="1">130</td><td align="center" rowspan="1" colspan="1">131</td><td align="center" rowspan="1" colspan="1">140</td></tr><tr><td align="left" rowspan="1" colspan="1">Potassium (mmol/L)</td><td align="center" rowspan="1" colspan="1">4.5 - 5.5</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">5</td></tr><tr><td align="left" rowspan="1" colspan="1">Calcium (mmol/L)</td><td align="center" rowspan="1" colspan="1">2.2 - 2.6</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">2.2</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">1.5</td><td align="center" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Magnesium (mmol/L)</td><td align="center" rowspan="1" colspan="1">0.8 - 1.0</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">1.5</td></tr><tr><td align="left" rowspan="1" colspan="1">Chloride (mmol/L)</td><td align="center" rowspan="1" colspan="1">94 - 111</td><td align="center" rowspan="1" colspan="1">154</td><td align="center" rowspan="1" colspan="1">156</td><td align="center" rowspan="1" colspan="1">111</td><td align="center" rowspan="1" colspan="1">109</td><td align="center" rowspan="1" colspan="1">110</td><td align="center" rowspan="1" colspan="1">98</td></tr><tr><td align="left" rowspan="1" colspan="1">Bicarbonate (mmol/L)</td><td align="center" rowspan="1" colspan="1">23 - 27</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Lactate (mmol/L)</td><td align="center" rowspan="1" colspan="1">1.0 - 2.0</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td align="left" rowspan="1" colspan="1">Acetate (mmol/L)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">27</td></tr><tr><td align="left" rowspan="1" colspan="1">Gluconate (mmol/L)</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">&#x000a0;</td><td align="center" rowspan="1" colspan="1">23</td></tr></tbody></table></table-wrap><sec><title>Unbalanced crystalloids</title><p>Sodium chloride (0.9% saline) is the most available and frequently used
crystalloid worldwide.<sup>(<xref rid="r3" ref-type="bibr">3</xref>)</sup>
Sodium chloride is an isotonic solution (osmolality closer to that of human
plasma) that contains equal concentrations of sodium and chloride (154mmol/L,
each) and therefore has an SID equal to zero (<xref ref-type="table" rid="t1">Table 1</xref>). Experimental<sup>(<xref rid="r14" ref-type="bibr">14</xref>-<xref rid="r22" ref-type="bibr">22</xref>)</sup> (<xref ref-type="table" rid="t2">Table 2</xref>) and clinical<sup>(<xref rid="r23" ref-type="bibr">23</xref>-<xref rid="r37" ref-type="bibr">37</xref>)</sup> studies (<xref ref-type="table" rid="t3">Table
3</xref>) have suggested that resuscitation with 0.9% saline has detrimental
effects on the kidneys, acid-base balance, and electrolyte homeostasis and may
affect tissue perfusion,<sup>(<xref rid="r38" ref-type="bibr">38</xref>)</sup>
inflammatory response,<sup>(<xref rid="r14" ref-type="bibr">14</xref>)</sup> and
coagulation (dilutional coagulopathy and/or profound hyperchloremic metabolic
acidosis).<sup>(<xref rid="r27" ref-type="bibr">27</xref>,<xref rid="r39" ref-type="bibr">39</xref>)</sup></p><table-wrap id="t2" orientation="portrait" position="float"><label>Table 2</label><caption><p>Summary of experimental studies comparing balanced with unbalanced
crystalloids</p></caption><table frame="box" rules="groups"><colgroup span="1"><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/><col width="25%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Author, year</th><th align="left" rowspan="1" colspan="1">Experimental model</th><th align="left" rowspan="1" colspan="1">Comparisons<xref ref-type="table-fn" rid="TFN6">*</xref></th><th align="left" rowspan="1" colspan="1">Main study findings</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Zhou et al.<sup>(<xref rid="r14" ref-type="bibr">14</xref>)</sup></td><td align="left" rowspan="1" colspan="1">Abdominal sepsis in rats</td><td align="left" rowspan="1" colspan="1">0.9% saline <break/> Plasma-Lyte</td><td align="left" rowspan="1" colspan="1">Higher serum chloride and lower pH with 0.9% saline
than with Plasma-Lyte. Higher incidence of AKI and lower
survival with 0.9% saline compared to Plasma-Lyte.</td></tr><tr><td align="left" rowspan="1" colspan="1">Healey et al.<sup>(<xref rid="r15" ref-type="bibr">15</xref>)</sup></td><td align="left" rowspan="1" colspan="1">Moderate hemorrhage and massive hemorrhage (35% and
218% of TBV removed, respectively) in rats</td><td align="left" rowspan="1" colspan="1">0.9% saline <break/> Ringer&#x02019;s lactate</td><td align="left" rowspan="1" colspan="1">No acid-base difference in moderate hemorrhage. In
massive hemorrhage, less acidosis and improved survival with
Ringer&#x02019;s lactate compared to 0.9% saline.</td></tr><tr><td align="left" rowspan="1" colspan="1">Watters et al.<sup>(<xref rid="r16" ref-type="bibr">16</xref>)</sup></td><td align="left" rowspan="1" colspan="1">Uncontrolled hemorrhagic shock in pigs</td><td align="left" rowspan="1" colspan="1">0.9% saline <break/> Ringer&#x02019;s Lactate</td><td align="left" rowspan="1" colspan="1">Lung inflammation was similar to 0.9% saline and
Ringer&#x02019;s lactate. </td></tr><tr><td align="left" rowspan="1" colspan="1">Todd et al.<sup>(<xref rid="r17" ref-type="bibr">17</xref>)</sup></td><td align="left" rowspan="1" colspan="1">Uncontrolled hemorrhagic shock in pigs</td><td align="left" rowspan="1" colspan="1">0.9% saline <break/> Ringer&#x02019;s lactate</td><td align="left" rowspan="1" colspan="1">Less Ringer&#x02019;s lactate than 0.9% saline was
necessary to restore baseline MAP. Higher urinary output with
0.9% saline than Ringer&#x02019;s lactate. Higher incidence of
hyperchloremic acidosis and lower fibrinogen levels with 0.9%
saline than with Ringer&#x02019;s lactate.</td></tr><tr><td align="left" rowspan="1" colspan="1">Noritomi et al.<sup>(<xref rid="r18" ref-type="bibr">18</xref>)</sup></td><td align="left" rowspan="1" colspan="1">Hemorrhagic shock in pigs (40% of TBV removed)</td><td align="left" rowspan="1" colspan="1">0.9% saline <break/> Ringer&#x02019;s lactate <break/>
Plasma-Lyte</td><td align="left" rowspan="1" colspan="1">Increased base excess and lower chloride levels
with Ringer&#x02019;s lactate and Plasma-Lyte compared to 0.9% saline.
Unmeasured anions did not differ between the groups.</td></tr><tr><td align="left" rowspan="1" colspan="1">Rohrig e R&#x000f6;nn.<sup>(<xref rid="r19" ref-type="bibr">19</xref>)</sup></td><td align="left" rowspan="1" colspan="1">Severe hemorrhagic shock in rats</td><td align="left" rowspan="1" colspan="1">Ringer&#x02019;s lactate <break/> Ringer&#x02019;s solution</td><td align="left" rowspan="1" colspan="1">Higher survival and lower incidence of AKI with
Ringer&#x02019;s solution than with Ringer&#x02019;s lactate.</td></tr><tr><td align="left" rowspan="1" colspan="1">Aksu et al.<sup>(<xref rid="r20" ref-type="bibr">20</xref>)</sup></td><td align="left" rowspan="1" colspan="1">Hemorrhagic shock in rats</td><td align="left" rowspan="1" colspan="1">0.9% saline <break/> Plasma-Lyte</td><td align="left" rowspan="1" colspan="1">Renal blood flow and kidney oxygen consumption
improved with Plasma-Lyte compared to 0.9% saline. Resuscitation
with Plasma-Lyte prevented hyperchloremia, restored acid-base
balance and preserved SID. No difference in systemic
inflammation nor in oxidative stress.</td></tr><tr><td align="left" rowspan="1" colspan="1">Martini et al.<sup>(<xref rid="r21" ref-type="bibr">21</xref>)</sup></td><td align="left" rowspan="1" colspan="1">Severe hemorrhagic shock (60% of TBV removed) in
pigs</td><td align="left" rowspan="1" colspan="1">0.9% saline <break/> Ringer&#x02019;s lactate</td><td align="left" rowspan="1" colspan="1">Lower volume of Ringer&#x02019;s lactate than 0.9% saline
necessary to restore baseline MAP. Base excess restored with
Ringer&#x02019;s lactate but not with 0.9% saline. Similar effects on
coagulation. Serum potassium increased with 0.9% saline while
unaffected with Ringer&#x02019;s Lactate.</td></tr><tr><td align="left" rowspan="1" colspan="1">Rohrig et al.<sup>(<xref rid="r22" ref-type="bibr">22</xref>)</sup></td><td align="left" rowspan="1" colspan="1">Severe hemorrhagic shock in rats</td><td align="left" rowspan="1" colspan="1">0.9% saline <break/> Ringer&#x02019;s lactate <break/>
Ringer&#x02019;s acetate <break/> Ringer&#x02019;s solution</td><td align="left" rowspan="1" colspan="1">Lower survival with Ringer&#x02019;s lactate than with all
other solutions. Pronounced metabolic acidosis with 0.9% saline
and Ringer&#x02019;s solutions than with Ringer&#x02019;s lactate and Ringer&#x02019;s
acetate.</td></tr></tbody></table><table-wrap-foot><fn id="TFN5"><p>AKI - acute kidney injury; TBV - total blood volume; MAP - mean
arterial blood pressure; SID - strong ion difference.</p></fn><fn id="TFN6"><label>*</label><p>comparisons other than 0.9% saline versus balanced solutions were not
considered.</p></fn></table-wrap-foot></table-wrap><table-wrap id="t3" orientation="portrait" position="float"><label>Table 3</label><caption><p>Summary of randomized controlled trials comparing balanced with
unbalanced crystalloids in clinical-surgical critically ill patients</p></caption><table frame="box" rules="groups"><colgroup span="1"><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/><col width="20%" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Author, year</th><th align="center" rowspan="1" colspan="1">N</th><th align="left" rowspan="1" colspan="1">Patients</th><th align="left" rowspan="1" colspan="1">Comparisons<xref ref-type="table-fn" rid="TFN8">*</xref></th><th align="left" rowspan="1" colspan="1">Main study findings</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">McFarlane e Lee<sup>(<xref rid="r23" ref-type="bibr">23</xref>)</sup></td><td align="center" rowspan="1" colspan="1">30</td><td align="left" rowspan="1" colspan="1">Open abdominal surgery</td><td align="left" rowspan="1" colspan="1">0.9% saline <break/> Plasma-Lyte</td><td align="left" rowspan="1" colspan="1">Acidosis and hyperchloremia with 0.9% saline.</td></tr><tr><td align="left" rowspan="1" colspan="1">Waters et al.<sup>(<xref rid="r24" ref-type="bibr">24</xref>)</sup></td><td align="center" rowspan="1" colspan="1">66</td><td align="left" rowspan="1" colspan="1">Aortic reconstructive surgery</td><td align="left" rowspan="1" colspan="1">0.9% saline <break/> Ringer&#x02019;s lactate</td><td align="left" rowspan="1" colspan="1">Acidosis, hyperchloremia and increased need of
platelets and blood products transfusion with 0.9% saline.</td></tr><tr><td align="left" rowspan="1" colspan="1">Takil et al.<sup>(<xref rid="r25" ref-type="bibr">25</xref>)</sup></td><td align="center" rowspan="1" colspan="1">30</td><td align="left" rowspan="1" colspan="1">Spinal surgery</td><td align="left" rowspan="1" colspan="1">0.9% saline <break/> Ringer&#x02019;s lactate</td><td align="left" rowspan="1" colspan="1">Acidosis and hyperchloremia with 0.9% saline.
Respiratory acidosis and mild hyponatremia with Ringer&#x02019;s
lactate.</td></tr><tr><td align="left" rowspan="1" colspan="1">Young et al.<sup>(<xref rid="r26" ref-type="bibr">26</xref>)</sup></td><td align="center" rowspan="1" colspan="1">46</td><td align="left" rowspan="1" colspan="1">Trauma</td><td align="left" rowspan="1" colspan="1">0.9% saline <break/> Plasma-Lyte</td><td align="left" rowspan="1" colspan="1">Acidosis and hyperchloremia with 0.9% saline.</td></tr><tr><td align="left" rowspan="1" colspan="1">Smith et al.<sup>(<xref rid="r27" ref-type="bibr">27</xref>)</sup></td><td align="center" rowspan="1" colspan="1">18</td><td align="left" rowspan="1" colspan="1">Trauma</td><td align="left" rowspan="1" colspan="1">0.9% saline <break/> Plasma-Lyte</td><td align="left" rowspan="1" colspan="1">Acidosis with 0.9% saline. Faster clot formation
with Plasma-Lyte. </td></tr><tr><td align="left" rowspan="1" colspan="1">O&#x02019;Malley et al.<sup>(<xref rid="r28" ref-type="bibr">28</xref>)</sup></td><td align="center" rowspan="1" colspan="1">51</td><td align="left" rowspan="1" colspan="1">Kidney transplantation</td><td align="left" rowspan="1" colspan="1">0.9% saline <break/> Ringer&#x02019;s lactate</td><td align="left" rowspan="1" colspan="1">Acidosis and hyperkalemia with 0.9% saline.</td></tr><tr><td align="left" rowspan="1" colspan="1">Khajavi et al.<sup>(<xref rid="r29" ref-type="bibr">29</xref>)</sup></td><td align="center" rowspan="1" colspan="1">52</td><td align="left" rowspan="1" colspan="1">Kidney transplantation</td><td align="left" rowspan="1" colspan="1">0.9% saline <break/> Ringer&#x02019;s lactate</td><td align="left" rowspan="1" colspan="1">More acidosis and hyperkalemia with 0.9% saline
than with Ringer&#x02019;s lactate.</td></tr><tr><td align="left" rowspan="1" colspan="1">Hadimioglu et al.<sup>(<xref rid="r30" ref-type="bibr">30</xref>)</sup></td><td align="center" rowspan="1" colspan="1">90</td><td align="left" rowspan="1" colspan="1">Kidney transplantation</td><td align="left" rowspan="1" colspan="1">0.9% saline <break/> Ringer&#x02019;s lactate <break/>
Plasma-Lyte</td><td align="left" rowspan="1" colspan="1">Hyperchloremic acidosis with 0.9% saline. Increased
lactate levels with Ringer&#x02019;s lactate. Potassium levels unchanged
in all groups.</td></tr><tr><td align="left" rowspan="1" colspan="1">Modi et al.<sup>(<xref rid="r31" ref-type="bibr">31</xref>)</sup></td><td align="center" rowspan="1" colspan="1">74</td><td align="left" rowspan="1" colspan="1">Kidney transplantation</td><td align="left" rowspan="1" colspan="1">0.9% saline <break/> Ringer&#x02019;s lactate</td><td align="left" rowspan="1" colspan="1">Acidosis, hyperchloremia and hyperkalemia with 0.9%
saline.</td></tr><tr><td align="left" rowspan="1" colspan="1">Kim et al.<sup>(<xref rid="r32" ref-type="bibr">32</xref>)</sup></td><td align="center" rowspan="1" colspan="1">60</td><td align="left" rowspan="1" colspan="1">Kidney transplantation</td><td align="left" rowspan="1" colspan="1">0.9% saline <break/> Plasma-Lyte</td><td align="left" rowspan="1" colspan="1">Acidosis and hyperchloremia with 0.9% saline.</td></tr><tr><td align="left" rowspan="1" colspan="1">Mahler et al.<sup>(<xref rid="r33" ref-type="bibr">33</xref>)</sup></td><td align="center" rowspan="1" colspan="1">45</td><td align="left" rowspan="1" colspan="1">Diabetic ketoacidosis</td><td align="left" rowspan="1" colspan="1">0.9% saline <break/> Plasma-Lyte</td><td align="left" rowspan="1" colspan="1">Hyperchloremic metabolic acidosis with 0.9%
saline.</td></tr><tr><td align="left" rowspan="1" colspan="1">Van Zyl et al.<sup>(<xref rid="r34" ref-type="bibr">34</xref>)</sup></td><td align="center" rowspan="1" colspan="1">54</td><td align="left" rowspan="1" colspan="1">Diabetic ketoacidosis</td><td align="left" rowspan="1" colspan="1">0.9% saline <break/> Ringer&#x02019;s lactate</td><td align="left" rowspan="1" colspan="1">Longer time to reach a blood glucose level of 14
mmol/L with Ringer&#x02019;s lactate.</td></tr><tr><td align="left" rowspan="1" colspan="1">Hasman et al.<sup>(<xref rid="r35" ref-type="bibr">35</xref>)</sup></td><td align="center" rowspan="1" colspan="1">90</td><td align="left" rowspan="1" colspan="1">Moderate or severe dehydration</td><td align="left" rowspan="1" colspan="1">0.9% saline <break/> Ringer&#x02019;s lactate <break/>
Plasma-Lyte</td><td align="left" rowspan="1" colspan="1">Pronounced acidosis with 0.9% saline.</td></tr><tr><td align="left" rowspan="1" colspan="1">Cieza et al.<sup>(<xref rid="r36" ref-type="bibr">36</xref>)</sup></td><td align="center" rowspan="1" colspan="1">40</td><td align="left" rowspan="1" colspan="1">Severe dehydration</td><td align="left" rowspan="1" colspan="1">0.9% saline <break/> Ringer&#x02019;s lactate</td><td align="left" rowspan="1" colspan="1">Acidosis and hyperchloremia with 0.9% saline.</td></tr><tr><td align="left" rowspan="1" colspan="1">Wu et al.<sup>(<xref rid="r37" ref-type="bibr">37</xref>)</sup></td><td align="center" rowspan="1" colspan="1">40</td><td align="left" rowspan="1" colspan="1">Acute pancreatitis</td><td align="left" rowspan="1" colspan="1">0.9% saline <break/> Ringer&#x02019;s lactate</td><td align="left" rowspan="1" colspan="1">Acidosis and hyperchloremia with 0.9% saline. Lower
incidence of SIRS and lower CRP levels 24 hours after
randomization in Ringer&#x02019;s lactate compared to 0.9% saline.</td></tr></tbody></table><table-wrap-foot><fn id="TFN7"><p>SIRS - systemic inflammatory response syndrome; CRP - C-reactive
protein.</p></fn><fn id="TFN8"><label>*</label><p>comparisons other than 0.9% saline versus balanced solutions were not
considered.</p></fn></table-wrap-foot></table-wrap><p>Hyperchloremia adversely affects kidney function.<sup>(<xref rid="r40" ref-type="bibr">40</xref>)</sup> Intrarenal (kidney artery) infusion of
chloride-containing solutions, such as 0.9% saline or ammonium chloride
(NH<sub>4</sub>Cl), leads to a reduced renal artery blood flow and
glomerular filtration rate in kidneys isolated from healthy dogs.<sup>(<xref rid="r41" ref-type="bibr">41</xref>)</sup> Intravascular volume
expansion with solutions containing supraphysiological chloride concentrations,
such as 0.9% saline, leads to increased chloride delivery to the macula densa
cells localized to the distal nephrons.<sup>(<xref rid="r40" ref-type="bibr">40</xref>)</sup> As a result, a number of signaling mediators, such as
adenosine, are released from macula densa cells into the kidney circulation
(tubuloglomerular feedback).<sup>(<xref rid="r42" ref-type="bibr">42</xref>)</sup> Adenosine has a strong constrictive effect on the renal
afferent arteriole, which compromises the renal blood flow, glomerular
filtration rate and, ultimately, kidney function.<sup>(<xref rid="r40" ref-type="bibr">40</xref>)</sup></p><p>The impact of intravascular volume expansion with unbalanced solutions (0.9%
saline) containing supraphysiological amounts of chloride on acid-base balance
and electrolyte homeostasis are better explained by the physicochemical Stewart
approach.<sup>(<xref rid="r43" ref-type="bibr">43</xref>)</sup>
Accordingly, strong cations (Na<sup>+</sup>, K<sup>+</sup>, Mg<sup>2+</sup> and
Ca<sup>2+</sup>) predominate in relation to strong anions (Cl<sup>-</sup>)
in the body, producing a net positive plasma charge of approximately 40mmol/L,
which is also known as the SID.<sup>(<xref rid="r43" ref-type="bibr">43</xref>)</sup> This positive plasma charge must be counterbalanced with
an equal negative charge to sustain the electrical neutrality (Law of
electro-neutrality). The balancing anionic charge is derived from nonvolatile
weak acids, mainly albumin and phosphate.<sup>(<xref rid="r43" ref-type="bibr">43</xref>)</sup> Infusion with large amounts of 0.9% saline produces
hyperchloremic metabolic acidosis in healthy volunteers and in different
populations of critically ill patients (<xref ref-type="table" rid="t3">Table
3</xref>).</p><p>Hyperchloremic metabolic acidosis occurs because 0.9% saline contains strong
cations and strong anions in the same quantity (SID equal to zero). When the
plasma chloride concentration increases after 0.9% saline infusion, the net
positive charge of plasma (SID) is reduced. Conversely, compensatory mechanisms
designed to maintain the plasma electro-neutrality are activated, thus
increasing the plasma positive charge (H<sup>+</sup>) while decreasing the
arterial pH.<sup>(<xref rid="r43" ref-type="bibr">43</xref>)</sup></p></sec><sec><title>Balanced crystalloids</title><p>Balanced crystalloids have been proposed as an alternative to unbalanced
solutions in order to mitigate their detrimental effects.<sup>(<xref rid="r3" ref-type="bibr">3</xref>)</sup> The most commonly available
balanced crystalloids are presented in <xref ref-type="table" rid="t1">table
1</xref>. Ringer's lactate is produced by adding sodium lactate as a buffer
to Ringer's solution to reduce its chloride concentration (<xref ref-type="table" rid="t1">Table 1</xref>). Concerns that large amounts of
Ringer's lactate infusion can increase plasma lactate levels in critically ill
patients have led to the development of Ringer's acetate, in which the lactate
buffer is replaced by acetate.<sup>(<xref rid="r30" ref-type="bibr">30</xref>)</sup> Thus, the composition of Ringer's lactate and Ringer's
acetate is almost identical with the exception of the added buffer (lactate or
acetate, respectively) (<xref ref-type="table" rid="t1">Table 1</xref>).</p><p>Plasma-Lyte is another balanced solution with an osmolality of 294mOsm/L and
sodium and chloride concentrations of 140mmol/L and of 98mmol/L, respectively.
Other electrolytes and buffers present in this solution include potassium,
magnesium, acetate and gluconate (<xref ref-type="table" rid="t1">Table
1</xref>). In the next sections, the current evidence comparing balanced and
unbalanced crystalloids in experimental models (<xref ref-type="table" rid="t2">Table 2</xref>) as well as in clinical studies involving healthy volunteers
and septic and non-septic critically ill patients (<xref ref-type="table" rid="t3">Table 3</xref>) is presented.</p></sec></sec><sec><title>EXPERIMENTAL STUDIES</title><p>Most experimental studies comparing a balanced solution, in general Ringer's lactate
or Plasma-Lyte, to an unbalanced solution (0.9% saline) were performed in animal
models of hemorrhagic shock<sup>(<xref rid="r15" ref-type="bibr">15</xref>-<xref rid="r22" ref-type="bibr">22</xref>)</sup> (<xref ref-type="table" rid="t2">Table 2</xref>). While resuscitation with 0.9% saline, but not with a balanced
solution, led to hyperchloremic metabolic acidosis,<sup>(<xref rid="r15" ref-type="bibr">15</xref>-<xref rid="r22" ref-type="bibr">22</xref>)</sup> renal
blood flow and kidney oxygen consumption were improved with Plasma-Lyte
resuscitation<sup>(<xref rid="r20" ref-type="bibr">20</xref>)</sup> (<xref ref-type="table" rid="t2">Table 2</xref>).</p><p>Plasma-Lyte was compared to 0.9% saline only in one experimental model of abdominal
sepsis (<xref ref-type="table" rid="t2">Table 2</xref>).<sup>(<xref rid="r14" ref-type="bibr">14</xref>)</sup> In this study, rats were randomly allocated to
resuscitation with either Plasma-Lyte or 0.9% saline, subcutaneously, eighteen hours
after a cecal ligation and puncture.<sup>(<xref rid="r14" ref-type="bibr">14</xref>)</sup> Resuscitation with Plasma-Lyte was associated with maintained
plasma chloride levels and arterial pH, lower plasma creatinine, lower urinary
cystatin C, lower neutrophil gelatinase-associated lipocalin (NGAL), lower plasma
interleukin-6 (IL-6), lower incidence (and severity) of acute kidney injury and a
higher survival rate than animals resuscitated with 0.9% saline. Serum potassium
levels, which are a major concern related to balanced crystalloids containing
potassium, did not differ between the groups.<sup>(<xref rid="r14" ref-type="bibr">14</xref>)</sup></p></sec><sec><title>STUDIES INVOLVING HEALTHY VOLUNTEERS</title><p>Four randomized crossover studies addressed the effects of 0.9% saline, Plasma-Lyte,
Ringer's lactate or Hartmann's solution on acid-base balance and electrolyte
disorders in healthy volunteers.<sup>(<xref rid="r44" ref-type="bibr">44</xref>-<xref rid="r47" ref-type="bibr">47</xref>)</sup> All studies
reported hyperchloremic metabolic acidosis following a 0.9% saline
infusion.<sup>(<xref rid="r44" ref-type="bibr">44</xref>-<xref rid="r47" ref-type="bibr">47</xref>)</sup></p><p>While 50mL/kg of Ringer's lactate infusion transiently decreased serum osmolality and
increased venous pH in healthy volunteers, a lower urinary output was seen after the
same amount of 0.9% saline infusion.<sup>(<xref rid="r44" ref-type="bibr">44</xref>)</sup> In another study, Reid et al. infused two liters of 0.9%
saline or Hartmann's solution for two hours in healthy volunteers on two separate
occasions.<sup>(<xref rid="r45" ref-type="bibr">45</xref>)</sup> In addition
to a more pronounced and sustained intravascular volume expansion with 0.9% saline
than with Hartmann's solution, urinary output was lower with 0.9% saline than with
Hartmann's solution.<sup>(<xref rid="r45" ref-type="bibr">45</xref>)</sup> The same
group compared 0.9% saline with Plasma-Lyte (two liters within one hour) in twelve
healthy volunteers on two separate occasions (up to 10 days apart).<sup>(<xref rid="r46" ref-type="bibr">46</xref>)</sup> In this study, Plasma-Lyte and
0.9% saline produced similar intravascular volume expansion. Nevertheless, 0.9%
saline yielded sustained hyperchloremia, reduced SID, increased extravascular volume
(edema) and lowered diuresis compared with Plasma-Lyte.<sup>(<xref rid="r46" ref-type="bibr">46</xref>)</sup> Additionally, renal artery flow velocity and
renal cortical perfusion assessed with magnetic resonance imaging were significantly
lower after 0.9% saline administration than after Plasma-Lyte. There was no
difference in urinary NGAL.<sup>(<xref rid="r46" ref-type="bibr">46</xref>)</sup></p></sec><sec><title>STUDIES IN SEPTIC AND NON-SEPTIC CRITICALLY ILL PATIENTS</title><p>There is limited data available supporting the use of balanced solutions in septic
shock patients.<sup>(<xref rid="r7" ref-type="bibr">7</xref>,<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r10" ref-type="bibr">10</xref>)</sup> A
meta-analysis including fourteen studies with 18,916 adult septic patients suggested
that resuscitation with balanced crystalloids compared with unbalanced crystalloids
(0.9% saline) may be associated with a lower mortality rate (odds ratio - OR, 0.78;
95% confidence interval - 95%CI, 0.58 to 1.05).<sup>(<xref rid="r7" ref-type="bibr">7</xref>)</sup> More recently, another network meta-analysis that included
ten randomized clinical trials with 6,664 septic patients showed no significant
difference in the need for renal replacement therapy (RRT) between balanced
crystalloids and 0.9% saline (OR, 0.85; 95% CI, 0.56 to 1.30).<sup>(<xref rid="r8" ref-type="bibr">8</xref>)</sup></p><p>Most studies comparing balanced and unbalanced crystalloids involved a mixed sample
of clinical-surgical critically ill patients<sup>(<xref rid="r23" ref-type="bibr">23</xref>-<xref rid="r37" ref-type="bibr">37</xref>,<xref rid="r48" ref-type="bibr">48</xref>-<xref rid="r51" ref-type="bibr">51</xref>)</sup> (<xref ref-type="table" rid="t3">Table 3</xref>). The safety and efficacy of volume
expansion with a balanced crystalloid (Plasma-Lyte 148) compared with that of 0.9%
saline were evaluated in a prospective, exploratory, cluster-randomized, blinded,
double-crossover trial.<sup>(<xref rid="r49" ref-type="bibr">49</xref>)</sup> In
this study, involving 2,278 critically ill patients, a median volume infusion of 2
liters of balanced crystalloid or 0.9% saline did not affect the risk of acute
kidney injury (AKI) according to RIFLE (Risk, Injury, Failure, Loss, and End-Stage)
classification (relative risk - RR, 1.04; 95%CI, 0.80 to 1.36; p = 0.77), the need
for RRT (RR, 0.96; 95%CI, 0.62 to 1.50; p = 0.91), ICU (RR, 0.92; 95%CI, 0.68 to
1.24; p = 0.62) or in-hospital mortality (RR, 0.88; 95%CI, 0.67 to 1.17; p =
0.40).<sup>(<xref rid="r49" ref-type="bibr">49</xref>)</sup> Nevertheless,
very few septic patients were included in this study, and acid-base and electrolyte
parameters were not provided. This precluded determination regarding how much
physiologic differentiation might have in fact occurred between the
groups.<sup>(<xref rid="r49" ref-type="bibr">49</xref>)</sup> Furthermore,
the effects on the primary outcome and other secondary binary outcomes were assessed
with simple chi-squared tests, ignoring the lack of independence of each patient's
observation caused by the cluster-randomized design of the study.<sup>(<xref rid="r52" ref-type="bibr">52</xref>)</sup> Consequently, the p-values were
artificially high, and the 95% CI was over-narrowed.</p><p>A chloride-liberal strategy was compared with a chloride-restrictive strategy among
critically ill adult patients in a before-after study.<sup>(<xref rid="r50" ref-type="bibr">50</xref>)</sup> During a six-month control period
(chloride-liberal period), 760 patients received intravenous fluids (0.9% saline, 4%
succinylated gelatin solution or 4% albumin) according to the clinician's
preference. After a 6-month interval, 773 patients received only chloride poor
fluids (Hartmann's solution, Plasma-Lyte or 20% albumin).<sup>(<xref rid="r50" ref-type="bibr">50</xref>)</sup> The authors demonstrated a significant decrease
in acute kidney injury and failure (from 14.0% to 8.4%; p &#x0003c; 0.001) according to
RIFLE classification and the need for RRT (from 10.0% to 6.3%; p = 0.005). No
differences in in-hospital mortality or other clinical outcomes were
observed.<sup>(<xref rid="r50" ref-type="bibr">50</xref>)</sup>
Contradictory findings were presented in a retrospective cohort study including
53,448 septic patients.<sup>(<xref rid="r48" ref-type="bibr">48</xref>)</sup> In
this observational study, resuscitation with balanced crystalloids, but not with
unbalanced crystalloids, was associated with decreased risk of in-hospital mortality
(RR, 0.86; 95%CI, 0.78 to 0.94; p = 0.001). Nevertheless, no significant difference
in the incidence of acute kidney injury, need for RRT, and hospital and ICU lengths
of stay was reported.<sup>(<xref rid="r48" ref-type="bibr">48</xref>)</sup></p><p>A propensity-matched cohort study with 3,116 hospitalized patients with a systemic
inflammatory response syndrome (SIRS) showed that balance crystalloids (Plasma-Lyte
or Normosol), compared with 0.9% saline, were associated with a lower rate of major
complications (atrial fibrillation, congestive heart failure, acute respiratory
failure, pneumonia, sepsis and coagulopathy), a lower frequency of electrolyte
abnormalities and hyperchloremic acidosis, shorter length of hospital stay, less
need for hospital re-admission, and lower in-hospital mortality.<sup>(<xref rid="r51" ref-type="bibr">51</xref>)</sup> Nevertheless, the incidence of
acute kidney injury did not differ between the groups studied.<sup>(<xref rid="r51" ref-type="bibr">51</xref>)</sup></p><p>Several small randomized trials compared balanced crystalloids with 0.9%
saline<sup>(<xref rid="r23" ref-type="bibr">23</xref>-<xref rid="r37" ref-type="bibr">37</xref>)</sup> (<xref ref-type="table" rid="t3">Table 3</xref>).
In most trials, 0.9% saline induced hyperchloremic metabolic acidosis compared with
either Ringer's lactate or Plasma-Lyte (<xref ref-type="table" rid="t3">Table
3</xref>). The effect of 0.9% saline versus Plasma-Lyte on coagulation
(thromboelastography) was recently evaluated in eighteen trauma patients.<sup>(<xref rid="r27" ref-type="bibr">27</xref>)</sup> The time from 2 to 20mm amplitude
(K) was shorter, and the &#x003b1; angle higher after intravascular expansion with
Plasma-Lyte than with 0.9% saline.<sup>(<xref rid="r27" ref-type="bibr">27</xref>)</sup> Coagulation derangements secondary to crystalloid infusion may
have clinical implications, as suggested by another study involving 66 patients
undergoing aortic reconstructive surgery.<sup>(<xref rid="r24" ref-type="bibr">24</xref>)</sup> In this study, patients who received 0.9% saline needed
more platelets and blood product transfusion than did those who received Ringer's
lactate.<sup>(<xref rid="r24" ref-type="bibr">24</xref>)</sup> The effect of
intravascular volume expansion with low-chloride versus high-chloride content
crystalloids in critically ill or surgical patients was recently addressed in a
meta-analysis.<sup>(<xref rid="r53" ref-type="bibr">53</xref>)</sup>
Twenty-one studies (15 randomized controlled trials) with 6,253 patients were
included. Although high-chloride containing crystalloids did not affect mortality,
they increased the risk of hyperchloremia and metabolic acidosis (risk ratio, 2.87;
95%CI, 1.95 to 4.21; p &#x0003c; 0.001) and the risk of acute kidney injury (risk ratio,
1.64; 95%CI, 1.27 to 2.13; p &#x0003c; 0.001).<sup>(<xref rid="r53" ref-type="bibr">53</xref>)</sup> Finally, there was an increase in blood transfusion volume
following resuscitation with 0.9% saline compared with low-chloride
crystalloids.<sup>(<xref rid="r53" ref-type="bibr">53</xref>)</sup></p><p>In summary, the current literature suggests that resuscitation of septic and
non-septic critically ill patients with unbalanced crystalloids, mainly 0.9% saline,
is associated with a higher incidence of acid-base balance and electrolyte
derangements. Most importantly, resuscitation with unbalanced crystalloids might be
associated with increased bleeding risk, an increased need for transfusion, a higher
incidence of acute kidney injury, an increased need for RRT and increased
mortality.</p></sec><sec><title>FUTURE DIRECTIONS</title><p>Although it appears that all crystalloid solutions have similar hemodynamic
effects,<sup>(<xref rid="r10" ref-type="bibr">10</xref>)</sup> the impact of
intravascular volume expansion with balanced solutions on regional and
microcirculatory blood flow, tissue perfusion, mitochondrial function, systemic
inflammation and coagulation need to be further evaluated in both experimental and
clinical studies.<sup>(<xref rid="r10" ref-type="bibr">10</xref>)</sup> Furthermore,
this review, as with any non-systematic narrative review, may have limitations in
terms of the comprehensiveness of the search strategy used to identify relevant
papers and the lack of standardization of methods for data extraction, analysis and
interpretation. Thus, systematic reviews with meta-analysis on the subject are
warranted.</p></sec><sec sec-type="conclusions"><title>CONCLUSION</title><p>Adequate fluid replacement is crucial to maintain perfusion pressure and, ultimately,
tissue perfusion in septic shock patients. Although the current sepsis guidelines
recommend crystalloids as first-line fluids for septic shock resuscitation, in the
light of the inconclusive nature of the available literature, no definitive
recommendations on the most appropriate crystalloid solution can be made. Therefore,
the safety and efficacy of balanced solutions, compared with 0.9% saline, for septic
shock resuscitation should be further evaluated in a large, multicenter, pragmatic,
randomized clinical trial.</p></sec></body><back><fn-group><fn fn-type="COI-statement"><p><bold>Conflicts of interest:</bold> None.</p></fn><fn fn-type="other"><p><bold>Responsible editor:</bold> Pedro P&#x000f3;voa</p></fn></fn-group><ack><title>ACKNOWLEDGEMENTS</title><p>We thank Helena Spalic for proofreading this manuscript.</p></ack><ref-list><title>REFER&#x000ca;NCIAS</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Angus</surname><given-names>DC</given-names></name><name><surname>van der Poll</surname><given-names>T</given-names></name></person-group><article-title>Severe sepsis and septic shock</article-title><source>N Engl J Med</source><year>2013</year><volume>369</volume><issue>9</issue><fpage>840</fpage><lpage>851</lpage><comment>Review. Erratum in: N Engl J Med. 2013;369(21):2069</comment><pub-id pub-id-type="pmid">23984731</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dellinger</surname><given-names>RP</given-names></name><name><surname>Levy</surname><given-names>MM</given-names></name><name><surname>Rhodes</surname><given-names>A</given-names></name><name><surname>Annane</surname><given-names>D</given-names></name><name><surname>Gerlach</surname><given-names>H</given-names></name><name><surname>Opal</surname><given-names>SM</given-names></name><name><surname>Sevransky</surname><given-names>JE</given-names></name><name><surname>Sprung</surname><given-names>CL</given-names></name><name><surname>Douglas</surname><given-names>IS</given-names></name><name><surname>Jaeschke</surname><given-names>R</given-names></name><name><surname>Osborn</surname><given-names>TM</given-names></name><name><surname>Nunnally</surname><given-names>ME</given-names></name><name><surname>Townsend</surname><given-names>SR</given-names></name><name><surname>Reinhart</surname><given-names>K</given-names></name><name><surname>Kleinpell</surname><given-names>RM</given-names></name><name><surname>Angus</surname><given-names>DC</given-names></name><name><surname>Deutschman</surname><given-names>CS</given-names></name><name><surname>Machado</surname><given-names>FR</given-names></name><name><surname>Rubenfeld</surname><given-names>GD</given-names></name><name><surname>Webb</surname><given-names>S</given-names></name><name><surname>Beale</surname><given-names>RJ</given-names></name><name><surname>Vincent</surname><given-names>JL</given-names></name><name><surname>Moreno</surname><given-names>R</given-names></name><collab>Surviving Sepsis Campaign Guidelines Committee including The
Pediatric Subgroup</collab></person-group><article-title>Surviving Sepsis Campaign: international guidelines for
management of severe sepsis and septic shock, 2012</article-title><source>Intensive Care Med</source><year>2013</year><volume>39</volume><issue>2</issue><fpage>165</fpage><lpage>228</lpage><pub-id pub-id-type="pmid">23361625</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myburgh</surname><given-names>JA</given-names></name><name><surname>Mythen</surname><given-names>MG</given-names></name></person-group><article-title>Resuscitation fluids</article-title><source>N Engl J Med</source><year>2013</year><volume>369</volume><issue>13</issue><fpage>1243</fpage><lpage>1251</lpage><comment>Review</comment><pub-id pub-id-type="pmid">24066745</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SJ</given-names></name><name><surname>Ramar</surname><given-names>K</given-names></name><name><surname>Park</surname><given-names>JG</given-names></name><name><surname>Gajic</surname><given-names>O</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Kashyap</surname><given-names>R</given-names></name></person-group><article-title>Increased fluid administration in the first three hours of sepsis
resuscitation is associated with reduced mortality: a retrospective cohort
study</article-title><source>Chest</source><year>2014</year><volume>146</volume><issue>4</issue><fpage>908</fpage><lpage>915</lpage><pub-id pub-id-type="pmid">24853382</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corr&#x000ea;a</surname><given-names>TD</given-names></name><name><surname>Vuda</surname><given-names>M</given-names></name><name><surname>Blaser</surname><given-names>AR</given-names></name><name><surname>Takala</surname><given-names>J</given-names></name><name><surname>Djafarzadeh</surname><given-names>S</given-names></name><name><surname>D&#x000fc;nser</surname><given-names>MW</given-names></name><etal/></person-group><article-title>Effect of treatment delay on disease severity and need for
resuscitation in porcine fecal peritonitis</article-title><source>Crit Care Med</source><year>2012</year><volume>40</volume><issue>10</issue><fpage>2841</fpage><lpage>2849</lpage><pub-id pub-id-type="pmid">22890256</pub-id></element-citation></ref><ref id="r6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyd</surname><given-names>JH</given-names></name><name><surname>Forbes</surname><given-names>J</given-names></name><name><surname>Nakada</surname><given-names>TA</given-names></name><name><surname>Walley</surname><given-names>KR</given-names></name><name><surname>Russell</surname><given-names>JA</given-names></name></person-group><article-title>Fluid resuscitation in septic shock: a positive fluid balance and
elevated central venous pressure are associated with increased
mortality</article-title><source>Crit Care Med</source><year>2011</year><volume>39</volume><issue>2</issue><fpage>259</fpage><lpage>265</lpage><pub-id pub-id-type="pmid">20975548</pub-id></element-citation></ref><ref id="r7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rochwerg</surname><given-names>B</given-names></name><name><surname>Alhazzani</surname><given-names>W</given-names></name><name><surname>Sindi</surname><given-names>A</given-names></name><name><surname>Heels-Ansdell</surname><given-names>D</given-names></name><name><surname>Thabane</surname><given-names>L</given-names></name><name><surname>Fox-Robichaud</surname><given-names>A</given-names></name><name><surname>Mbuagbaw</surname><given-names>L</given-names></name><name><surname>Szczeklik</surname><given-names>W</given-names></name><name><surname>Alshamsi</surname><given-names>F</given-names></name><name><surname>Altayyar</surname><given-names>S</given-names></name><name><surname>Ip</surname><given-names>WC</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Wludarczyk</surname><given-names>A</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Guyatt</surname><given-names>GH</given-names></name><name><surname>Cook</surname><given-names>DJ</given-names></name><name><surname>Jaeschke</surname><given-names>R</given-names></name><name><surname>Annane</surname><given-names>D</given-names></name><collab>Fluids in Sepsis and Septic Shock Group</collab></person-group><article-title>Fluid resuscitation in sepsis: a systematic review and network
meta-analysis</article-title><source>Ann Intern Med</source><year>2014</year><volume>161</volume><issue>5</issue><fpage>347</fpage><lpage>355</lpage><comment>Review</comment><pub-id pub-id-type="pmid">25047428</pub-id></element-citation></ref><ref id="r8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rochwerg</surname><given-names>B</given-names></name><name><surname>Alhazzani</surname><given-names>W</given-names></name><name><surname>Gibson</surname><given-names>A</given-names></name><name><surname>Ribic</surname><given-names>CM</given-names></name><name><surname>Sindi</surname><given-names>A</given-names></name><name><surname>Heels-Ansdell</surname><given-names>D</given-names></name><name><surname>Thabane</surname><given-names>L</given-names></name><name><surname>Fox-Robichaud</surname><given-names>A</given-names></name><name><surname>Mbuagbaw</surname><given-names>L</given-names></name><name><surname>Szczeklik</surname><given-names>W</given-names></name><name><surname>Alshamsi</surname><given-names>F</given-names></name><name><surname>Altayyar</surname><given-names>S</given-names></name><name><surname>Ip</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Wludarczyk</surname><given-names>A</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Annane</surname><given-names>D</given-names></name><name><surname>Cook</surname><given-names>DJ</given-names></name><name><surname>Jaeschke</surname><given-names>R</given-names></name><name><surname>Guyatt</surname><given-names>GH</given-names></name><collab>FISSH Group (Fluids in Sepsis and Septic Shock)</collab></person-group><article-title>Fluid type and the use of renal replacement therapy in sepsis: a
systematic review and network meta-analysis</article-title><source>Intensive Care Med</source><year>2015</year><volume>41</volume><issue>9</issue><fpage>1561</fpage><lpage>1571</lpage><comment>Review</comment><pub-id pub-id-type="pmid">25904181</pub-id></element-citation></ref><ref id="r9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cecconi</surname><given-names>M</given-names></name><name><surname>Hofer</surname><given-names>C</given-names></name><name><surname>Teboul</surname><given-names>JL</given-names></name><name><surname>Pettila</surname><given-names>V</given-names></name><name><surname>Wilkman</surname><given-names>E</given-names></name><name><surname>Molnar</surname><given-names>Z</given-names></name><name><surname>Della Rocca</surname><given-names>G</given-names></name><name><surname>Aldecoa</surname><given-names>C</given-names></name><name><surname>Artigas</surname><given-names>A</given-names></name><name><surname>Jog</surname><given-names>S</given-names></name><name><surname>Sander</surname><given-names>M</given-names></name><name><surname>Spies</surname><given-names>C</given-names></name><name><surname>Lefrant</surname><given-names>JY</given-names></name><name><surname>De Backer</surname><given-names>D</given-names></name><collab>FENICE Investigators</collab><collab>ESICM Trial Group</collab></person-group><article-title>Fluid challenges in intensive care: the FENICE study: A global
inception cohort study</article-title><source>Intensive Care Med</source><year>2015</year><volume>41</volume><issue>9</issue><fpage>1529</fpage><lpage>1537</lpage><comment>Erratum in Intensive Care Med. 2015;41(9):1737-8</comment><pub-id pub-id-type="pmid">26162676</pub-id></element-citation></ref><ref id="r10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orbegozo Cort&#x000e9;s</surname><given-names>D</given-names></name><name><surname>Rayo Bonor</surname><given-names>A</given-names></name><name><surname>Vincent</surname><given-names>JL</given-names></name></person-group><article-title>Isotonic crystalloid solutions: a structured review of the
literature</article-title><source>Br J Anaesth</source><year>2014</year><volume>112</volume><issue>6</issue><fpage>968</fpage><lpage>981</lpage><pub-id pub-id-type="pmid">24736393</pub-id></element-citation></ref><ref id="r11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raghunathan</surname><given-names>K</given-names></name><name><surname>Murray</surname><given-names>PT</given-names></name><name><surname>Beattie</surname><given-names>WS</given-names></name><name><surname>Lobo</surname><given-names>DN</given-names></name><name><surname>Myburgh</surname><given-names>J</given-names></name><name><surname>Sladen</surname><given-names>R</given-names></name><name><surname>Kellum</surname><given-names>JA</given-names></name><name><surname>Mythen</surname><given-names>MG</given-names></name><name><surname>Shaw</surname><given-names>AD</given-names></name><collab>ADQI XII Investigators Group</collab></person-group><article-title>Choice of fluid in acute illness: what should be given? An
international consensus</article-title><source>Br J Anaesth</source><year>2014</year><volume>113</volume><issue>5</issue><fpage>772</fpage><lpage>783</lpage><pub-id pub-id-type="pmid">25326478</pub-id></element-citation></ref><ref id="r12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haynes</surname><given-names>RB</given-names></name><name><surname>McKibbon</surname><given-names>KA</given-names></name><name><surname>Wilczynski</surname><given-names>NL</given-names></name><name><surname>Walter</surname><given-names>SD</given-names></name><name><surname>Werre</surname><given-names>SR</given-names></name><collab>Hedges Team</collab></person-group><article-title>Optimal search strategies for retrieving scientifically strong
studies of treatment from Medline: analytical survey</article-title><source>BMJ</source><year>2005</year><volume>330</volume><issue>7501</issue><fpage>1179</fpage><lpage>1179</lpage><pub-id pub-id-type="pmid">15894554</pub-id></element-citation></ref><ref id="r13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>TJ</given-names></name></person-group><article-title>The ideal crystalloid - what is 'balanced'?</article-title><source>Curr Opin Crit Care</source><year>2013</year><volume>19</volume><issue>4</issue><fpage>299</fpage><lpage>307</lpage><pub-id pub-id-type="pmid">23743589</pub-id></element-citation></ref><ref id="r14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>F</given-names></name><name><surname>Peng</surname><given-names>ZY</given-names></name><name><surname>Bishop</surname><given-names>JV</given-names></name><name><surname>Cove</surname><given-names>ME</given-names></name><name><surname>Singbartl</surname><given-names>K</given-names></name><name><surname>Kellum</surname><given-names>JA</given-names></name></person-group><article-title>Effects of fluid resuscitation with 0.9% saline versus a balanced
electrolyte solution on acute kidney injury in a rat model of
sepsis*</article-title><source>Crit Care Med</source><year>2014</year><volume>42</volume><issue>4</issue><fpage>e270</fpage><lpage>e278</lpage><pub-id pub-id-type="pmid">24335444</pub-id></element-citation></ref><ref id="r15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Healey</surname><given-names>MA</given-names></name><name><surname>Davis</surname><given-names>RE</given-names></name><name><surname>Liu</surname><given-names>FC</given-names></name><name><surname>Loomis</surname><given-names>WH</given-names></name><name><surname>Hoyt</surname><given-names>DB</given-names></name></person-group><article-title>Lactated ringer's is superior to normal saline in a model of
massive hemorrhage and resuscitation</article-title><source>J Trauma</source><year>1998</year><volume>45</volume><issue>5</issue><fpage>894</fpage><lpage>899</lpage><pub-id pub-id-type="pmid">9820700</pub-id></element-citation></ref><ref id="r16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watters</surname><given-names>JM</given-names></name><name><surname>Brundage</surname><given-names>SI</given-names></name><name><surname>Todd</surname><given-names>SR</given-names></name><name><surname>Zautke</surname><given-names>NA</given-names></name><name><surname>Stefater</surname><given-names>JA</given-names></name><name><surname>Lam</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Resuscitation with lactated ringer's does not increase
inflammatory response in a Swine model of uncontrolled hemorrhagic
shock</article-title><source>Shock</source><year>2004</year><volume>22</volume><issue>3</issue><fpage>283</fpage><lpage>287</lpage><pub-id pub-id-type="pmid">15316400</pub-id></element-citation></ref><ref id="r17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Todd</surname><given-names>SR</given-names></name><name><surname>Malinoski</surname><given-names>D</given-names></name><name><surname>Muller</surname><given-names>PJ</given-names></name><name><surname>Schreiber</surname><given-names>MA</given-names></name></person-group><article-title>Lactated Ringer's is superior to normal saline in the
resuscitation of uncontrolled hemorrhagic shock</article-title><source>J Trauma</source><year>2007</year><volume>62</volume><issue>3</issue><fpage>636</fpage><lpage>639</lpage><pub-id pub-id-type="pmid">17414340</pub-id></element-citation></ref><ref id="r18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noritomi</surname><given-names>DT</given-names></name><name><surname>Pereira</surname><given-names>AJ</given-names></name><name><surname>Bugano</surname><given-names>DD</given-names></name><name><surname>Rehder</surname><given-names>PS</given-names></name><name><surname>Silva</surname><given-names>E</given-names></name></person-group><article-title>Impact of Plasma-Lyte pH 7.4 on acid-base status and hemodynamics
in a model of controlled hemorrhagic shock</article-title><source>Clinics (S&#x000e3;o Paulo)</source><year>2011</year><volume>66</volume><issue>11</issue><fpage>1969</fpage><lpage>1974</lpage><pub-id pub-id-type="pmid">22086530</pub-id></element-citation></ref><ref id="r19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohrig</surname><given-names>R</given-names></name><name><surname>R&#x000f6;nn</surname><given-names>T</given-names></name><name><surname>Lendemans</surname><given-names>S</given-names></name><name><surname>Feldkamp</surname><given-names>T</given-names></name><name><surname>de Groot</surname><given-names>H</given-names></name><name><surname>Petrat</surname><given-names>F</given-names></name></person-group><article-title>Adverse effects of resuscitation with lactated ringer compared
with ringer solution after severe hemorrhagic shock in rats</article-title><source>Shock</source><year>2012</year><volume>38</volume><issue>2</issue><fpage>137</fpage><lpage>145</lpage><pub-id pub-id-type="pmid">22683725</pub-id></element-citation></ref><ref id="r20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aksu</surname><given-names>U</given-names></name><name><surname>Bezemer</surname><given-names>R</given-names></name><name><surname>Yavuz</surname><given-names>B</given-names></name><name><surname>Kandil</surname><given-names>A</given-names></name><name><surname>Demirci</surname><given-names>C</given-names></name><name><surname>Ince</surname><given-names>C</given-names></name></person-group><article-title>Balanced vs unbalanced crystalloid resuscitation in a near-fatal
model of hemorrhagic shock and the effects on renal oxygenation, oxidative
stress, and inflammation</article-title><source>Resuscitation</source><year>2012</year><volume>83</volume><issue>6</issue><fpage>767</fpage><lpage>773</lpage><pub-id pub-id-type="pmid">22142654</pub-id></element-citation></ref><ref id="r21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martini</surname><given-names>WZ</given-names></name><name><surname>Cortez</surname><given-names>DS</given-names></name><name><surname>Dubick</surname><given-names>MA</given-names></name></person-group><article-title>Comparisons of normal saline and lactated Ringer's resuscitation
on hemodynamics, metabolic responses, and coagulation in pigs after severe
hemorrhagic shock</article-title><source>Scand J Trauma Resusc Emerg Med</source><year>2013</year><volume>21</volume><fpage>86</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">24330733</pub-id></element-citation></ref><ref id="r22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rohrig</surname><given-names>R</given-names></name><name><surname>Wegewitz</surname><given-names>C</given-names></name><name><surname>Lendemans</surname><given-names>S</given-names></name><name><surname>Petrat</surname><given-names>F</given-names></name><name><surname>de Groot</surname><given-names>H</given-names></name></person-group><article-title>Superiority of acetate compared with lactate in a rodent model of
severe hemorrhagic shock</article-title><source>J Surg Res</source><year>2014</year><volume>186</volume><issue>1</issue><fpage>338</fpage><lpage>345</lpage><pub-id pub-id-type="pmid">24124975</pub-id></element-citation></ref><ref id="r23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McFarlane</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>A</given-names></name></person-group><article-title>A comparison of Plasmalyte 148 and 0.9% saline for
intra-operative fluid replacement</article-title><source>Anaesthesia</source><year>1994</year><volume>49</volume><issue>9</issue><fpage>779</fpage><lpage>781</lpage><pub-id pub-id-type="pmid">7978133</pub-id></element-citation></ref><ref id="r24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waters</surname><given-names>JH</given-names></name><name><surname>Gottlieb</surname><given-names>A</given-names></name><name><surname>Schoenwald</surname><given-names>P</given-names></name><name><surname>Popovich</surname><given-names>MJ</given-names></name><name><surname>Sprung</surname><given-names>J</given-names></name><name><surname>Nelson</surname><given-names>DR</given-names></name></person-group><article-title>Normal saline versus lactated Ringer's solution for
intraoperative fluid management in patients undergoing abdominal aortic
aneurysm repair: an outcome study</article-title><source>Anesth Analg</source><year>2001</year><volume>93</volume><issue>4</issue><fpage>817</fpage><lpage>822</lpage><pub-id pub-id-type="pmid">11574339</pub-id></element-citation></ref><ref id="r25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takil</surname><given-names>A</given-names></name><name><surname>Eti</surname><given-names>Z</given-names></name><name><surname>Irmak</surname><given-names>P</given-names></name><name><surname>Yilmaz G&#x000f6;g&#x000fc;s</surname><given-names>F</given-names></name></person-group><article-title>Early postoperative respiratory acidosis after large
intravascular volume infusion of lactated ringer's solution during major
spine surgery</article-title><source>Anesth Analg</source><year>2002</year><volume>95</volume><issue>2</issue><fpage>294</fpage><lpage>298</lpage><comment>table of contents</comment><pub-id pub-id-type="pmid">12145036</pub-id></element-citation></ref><ref id="r26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>JB</given-names></name><name><surname>Utter</surname><given-names>GH</given-names></name><name><surname>Schermer</surname><given-names>CR</given-names></name><name><surname>Galante</surname><given-names>JM</given-names></name><name><surname>Phan</surname><given-names>HH</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Saline versus Plasma-Lyte A in initial resuscitation of trauma
patients: a randomized trial</article-title><source>Ann Surg</source><year>2014</year><volume>259</volume><issue>2</issue><fpage>255</fpage><lpage>262</lpage><pub-id pub-id-type="pmid">23732264</pub-id></element-citation></ref><ref id="r27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>CA</given-names></name><name><surname>Gosselin</surname><given-names>RC</given-names></name><name><surname>Utter</surname><given-names>GH</given-names></name><name><surname>Galante</surname><given-names>JM</given-names></name><name><surname>Young</surname><given-names>JB</given-names></name><name><surname>Scherer</surname><given-names>LA</given-names></name><etal/></person-group><article-title>Does saline resuscitation affect mechanisms of coagulopathy in
critically ill trauma patients? An exploratory analysis</article-title><source>Blood Coagul Fibrinolysis</source><year>2015</year><volume>26</volume><issue>3</issue><fpage>250</fpage><lpage>254</lpage><pub-id pub-id-type="pmid">25803514</pub-id></element-citation></ref><ref id="r28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Malley</surname><given-names>CM</given-names></name><name><surname>Frumento</surname><given-names>RJ</given-names></name><name><surname>Hardy</surname><given-names>MA</given-names></name><name><surname>Benvenisty</surname><given-names>AI</given-names></name><name><surname>Brentjens</surname><given-names>TE</given-names></name><name><surname>Mercer</surname><given-names>JS</given-names></name><etal/></person-group><article-title>A randomized, double-blind comparison of lactated Ringer's
solution and 0.9% NaCl during renal transplantation</article-title><source>Anesth Analg</source><year>2005</year><volume>100</volume><issue>5</issue><fpage>1518</fpage><lpage>1524</lpage><comment>table of contents</comment><pub-id pub-id-type="pmid">15845718</pub-id></element-citation></ref><ref id="r29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khajavi</surname><given-names>MR</given-names></name><name><surname>Etezadi</surname><given-names>F</given-names></name><name><surname>Moharari</surname><given-names>RS</given-names></name><name><surname>Imani</surname><given-names>F</given-names></name><name><surname>Meysamie</surname><given-names>AP</given-names></name><name><surname>Khashayar</surname><given-names>P</given-names></name><etal/></person-group><article-title>Effects of normal saline vs. lactated ringer's during renal
transplantation</article-title><source>Ren Fail</source><year>2008</year><volume>30</volume><issue>5</issue><fpage>535</fpage><lpage>539</lpage><pub-id pub-id-type="pmid">18569935</pub-id></element-citation></ref><ref id="r30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hadimioglu</surname><given-names>N</given-names></name><name><surname>Saadawy</surname><given-names>I</given-names></name><name><surname>Saglam</surname><given-names>T</given-names></name><name><surname>Ertug</surname><given-names>Z</given-names></name><name><surname>Dinckan</surname><given-names>A</given-names></name></person-group><article-title>The effect of different crystalloid solutions on acid-base
balance and early kidney function after kidney
transplantation</article-title><source>Anesth Analg</source><year>2008</year><volume>107</volume><issue>1</issue><fpage>264</fpage><lpage>269</lpage><pub-id pub-id-type="pmid">18635497</pub-id></element-citation></ref><ref id="r31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Modi</surname><given-names>MP</given-names></name><name><surname>Vora</surname><given-names>KS</given-names></name><name><surname>Parikh</surname><given-names>GP</given-names></name><name><surname>Shah</surname><given-names>VR</given-names></name></person-group><article-title>A comparative study of impact of infusion of Ringer's Lactate
solution versus normal saline on acid-base balance and serum electrolytes
during live related renal transplantation</article-title><source>Saudi J Kidney Dis Transpl</source><year>2012</year><volume>23</volume><issue>1</issue><fpage>135</fpage><lpage>137</lpage><pub-id pub-id-type="pmid">22237237</pub-id></element-citation></ref><ref id="r32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Huh</surname><given-names>KH</given-names></name><name><surname>Lee</surname><given-names>JR</given-names></name><name><surname>Kim</surname><given-names>SH</given-names></name><name><surname>Jeong</surname><given-names>SH</given-names></name><name><surname>Choi</surname><given-names>YS</given-names></name></person-group><article-title>Comparison of the effects of normal saline versus Plasmalyte on
acid-base balance during living donor kidney transplantation using the
Stewart and base excess methods</article-title><source>Transplant Proc</source><year>2013</year><volume>45</volume><issue>6</issue><fpage>2191</fpage><lpage>2196</lpage><pub-id pub-id-type="pmid">23953528</pub-id></element-citation></ref><ref id="r33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahler</surname><given-names>SA</given-names></name><name><surname>Conrad</surname><given-names>SA</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Arnold</surname><given-names>TC</given-names></name></person-group><article-title>Resuscitation with balanced electrolyte solution prevents
hyperchloremic metabolic acidosis in patients with diabetic
ketoacidosis</article-title><source>Am J Emerg Med</source><year>2011</year><volume>29</volume><issue>6</issue><fpage>670</fpage><lpage>674</lpage><pub-id pub-id-type="pmid">20825879</pub-id></element-citation></ref><ref id="r34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Zyl</surname><given-names>DG</given-names></name><name><surname>Rheeder</surname><given-names>P</given-names></name><name><surname>Delport</surname><given-names>E</given-names></name></person-group><article-title>Fluid management in diabetic-acidosis-Ringer's lactate versus
normal saline: a randomized controlled trial</article-title><source>QJM</source><year>2012</year><volume>105</volume><issue>4</issue><fpage>337</fpage><lpage>343</lpage><pub-id pub-id-type="pmid">22109683</pub-id></element-citation></ref><ref id="r35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasman</surname><given-names>H</given-names></name><name><surname>Cinar</surname><given-names>O</given-names></name><name><surname>Uzun</surname><given-names>A</given-names></name><name><surname>Cevik</surname><given-names>E</given-names></name><name><surname>Jay</surname><given-names>L</given-names></name><name><surname>Comert</surname><given-names>B</given-names></name></person-group><article-title>A randomized clinical trial comparing the effect of rapidly
infused crystalloids on acid-base status in dehydrated patients in the
emergency department</article-title><source>Int J Med Sci</source><year>2012</year><volume>9</volume><issue>1</issue><fpage>59</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">22211091</pub-id></element-citation></ref><ref id="r36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cieza</surname><given-names>JA</given-names></name><name><surname>Hinostroza</surname><given-names>J</given-names></name><name><surname>Huapaya</surname><given-names>JA</given-names></name><name><surname>Le&#x000f3;n</surname><given-names>CP</given-names></name></person-group><article-title>Sodium chloride 0.9% versus Lactated Ringer in the management of
severely dehydrated patients with choleriform diarrhoea</article-title><source>J Infect Dev Ctries</source><year>2013</year><volume>7</volume><issue>7</issue><fpage>528</fpage><lpage>532</lpage><pub-id pub-id-type="pmid">23857387</pub-id></element-citation></ref><ref id="r37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>BU</given-names></name><name><surname>Hwang</surname><given-names>JQ</given-names></name><name><surname>Gardner</surname><given-names>TH</given-names></name><name><surname>Repas</surname><given-names>K</given-names></name><name><surname>Delee</surname><given-names>R</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><etal/></person-group><article-title>Lactated Ringer's solution reduces systemic inflammation compared
with saline in patients with acute pancreatitis</article-title><source>Clin Gastroenterol Hepatol</source><year>2011</year><volume>9</volume><issue>8</issue><fpage>710</fpage><lpage>717</lpage><page-range>710-717.e1</page-range><pub-id pub-id-type="pmid">21645639</pub-id></element-citation></ref><ref id="r38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gruartmoner</surname><given-names>G</given-names></name><name><surname>Mesquida</surname><given-names>J</given-names></name><name><surname>Ince</surname><given-names>C</given-names></name></person-group><article-title>Fluid therapy and the hypovolemic
microcirculation</article-title><source>Curr Opin Crit Care</source><year>2015</year><volume>21</volume><issue>4</issue><fpage>276</fpage><lpage>284</lpage><pub-id pub-id-type="pmid">26103148</pub-id></element-citation></ref><ref id="r39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kozek-Langenecker</surname><given-names>SA</given-names></name></person-group><article-title>Fluids and coagulation</article-title><source>Curr Opin Crit Care</source><year>2015</year><volume>21</volume><issue>4</issue><fpage>285</fpage><lpage>291</lpage><pub-id pub-id-type="pmid">26103143</pub-id></element-citation></ref><ref id="r40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martensson</surname><given-names>J</given-names></name><name><surname>Bellomo</surname><given-names>R</given-names></name></person-group><article-title>Are all fluids bad for the kidney?</article-title><source>Curr Opin Crit Care</source><year>2015</year><volume>21</volume><issue>4</issue><fpage>292</fpage><lpage>301</lpage><pub-id pub-id-type="pmid">26103141</pub-id></element-citation></ref><ref id="r41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilcox</surname><given-names>CS</given-names></name></person-group><article-title>Regulation of renal blood flow by plasma chloride</article-title><source>J Clin Invest</source><year>1983</year><volume>71</volume><issue>3</issue><fpage>726</fpage><lpage>735</lpage><pub-id pub-id-type="pmid">6826732</pub-id></element-citation></ref><ref id="r42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vallon</surname><given-names>V</given-names></name><name><surname>M&#x000fc;hlbauer</surname><given-names>B</given-names></name><name><surname>Osswald</surname><given-names>H</given-names></name></person-group><article-title>Adenosine and kidney function</article-title><source>Physiol Rev</source><year>2006</year><volume>86</volume><issue>3</issue><fpage>901</fpage><lpage>940</lpage><pub-id pub-id-type="pmid">16816141</pub-id></element-citation></ref><ref id="r43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seifter</surname><given-names>JL</given-names></name></person-group><article-title>Integration of acid-base and electrolyte
disorders</article-title><source>N Engl J Med</source><year>2014</year><volume>371</volume><issue>19</issue><fpage>1821</fpage><lpage>1831</lpage><pub-id pub-id-type="pmid">25372090</pub-id></element-citation></ref><ref id="r44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>EL</given-names></name><name><surname>Hildebrand</surname><given-names>KL</given-names></name><name><surname>McCormick</surname><given-names>SA</given-names></name><name><surname>Bedel</surname><given-names>MJ</given-names></name></person-group><article-title>The effect of intravenous lactated Ringer's solution versus 0.9%
sodium chloride solution on serum osmolality in human
volunteers</article-title><source>Anesth Analg</source><year>1999</year><volume>88</volume><issue>5</issue><fpage>999</fpage><lpage>1003</lpage><pub-id pub-id-type="pmid">10320158</pub-id></element-citation></ref><ref id="r45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reid</surname><given-names>F</given-names></name><name><surname>Lobo</surname><given-names>DN</given-names></name><name><surname>Williams</surname><given-names>RN</given-names></name><name><surname>Rowlands</surname><given-names>BJ</given-names></name><name><surname>Allison</surname><given-names>SP</given-names></name></person-group><article-title>(Ab)normal saline and physiological Hartmann's solution: a
randomized double-blind crossover study</article-title><source>Clin Sci (Lond)</source><year>2003</year><volume>104</volume><issue>1</issue><fpage>17</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">12519083</pub-id></element-citation></ref><ref id="r46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chowdhury</surname><given-names>AH</given-names></name><name><surname>Cox</surname><given-names>EF</given-names></name><name><surname>Francis</surname><given-names>ST</given-names></name><name><surname>Lobo</surname><given-names>DN</given-names></name></person-group><article-title>A randomized, controlled, double-blind crossover study on the
effects of 2-L infusions of 0.9% saline and plasma-lyte<sup>&#x000ae;</sup>
148 on renal blood flow velocity and renal cortical tissue perfusion in
healthy volunteers</article-title><source>Ann Surg</source><year>2012</year><volume>256</volume><issue>1</issue><fpage>18</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">22580944</pub-id></element-citation></ref><ref id="r47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Story</surname><given-names>DA</given-names></name><name><surname>Lees</surname><given-names>L</given-names></name><name><surname>Weinberg</surname><given-names>L</given-names></name><name><surname>Teoh</surname><given-names>SY</given-names></name><name><surname>Lee</surname><given-names>KJ</given-names></name><name><surname>Velissaris</surname><given-names>S</given-names></name><etal/></person-group><article-title>Cognitive changes after saline or plasmalyte infusion in healthy
volunteers: a multiple blinded, randomized, cross-over trial</article-title><source>Anesthesiology</source><year>2013</year><volume>119</volume><issue>3</issue><fpage>569</fpage><lpage>575</lpage><pub-id pub-id-type="pmid">23598288</pub-id></element-citation></ref><ref id="r48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raghunathan</surname><given-names>K</given-names></name><name><surname>Shaw</surname><given-names>A</given-names></name><name><surname>Nathanson</surname><given-names>B</given-names></name><name><surname>St&#x000fc;rmer</surname><given-names>T</given-names></name><name><surname>Brookhart</surname><given-names>A</given-names></name><name><surname>Stefan</surname><given-names>MS</given-names></name><etal/></person-group><article-title>Association between the choice of IV crystalloid and in-hospital
mortality among critically ill adults with sepsis*</article-title><source>Crit Care Med</source><year>2014</year><volume>42</volume><issue>7</issue><fpage>1585</fpage><lpage>1591</lpage><pub-id pub-id-type="pmid">24674927</pub-id></element-citation></ref><ref id="r49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>P</given-names></name><name><surname>Bailey</surname><given-names>M</given-names></name><name><surname>Beasley</surname><given-names>R</given-names></name><name><surname>Henderson</surname><given-names>S</given-names></name><name><surname>Mackle</surname><given-names>D</given-names></name><name><surname>McArthur</surname><given-names>C</given-names></name><name><surname>McGuinness</surname><given-names>S</given-names></name><name><surname>Mehrtens</surname><given-names>J</given-names></name><name><surname>Myburgh</surname><given-names>J</given-names></name><name><surname>Psirides</surname><given-names>A</given-names></name><name><surname>Reddy</surname><given-names>S</given-names></name><name><surname>Bellomo</surname><given-names>R</given-names></name><collab>SPLIT Investigators</collab><collab>ANZICS CTG</collab></person-group><article-title>Effect of a Buffered Crystalloid Solution vs Saline on Acute
Kidney Injury Among Patients in the Intensive Care Unit: The SPLIT
Randomized Clinical Trial</article-title><source>JAMA</source><year>2015</year><volume>314</volume><issue>16</issue><fpage>1701</fpage><lpage>1710</lpage><pub-id pub-id-type="pmid">26444692</pub-id></element-citation></ref><ref id="r50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yunos</surname><given-names>NM</given-names></name><name><surname>Bellomo</surname><given-names>R</given-names></name><name><surname>Hegarty</surname><given-names>C</given-names></name><name><surname>Story</surname><given-names>D</given-names></name><name><surname>Ho</surname><given-names>L</given-names></name><name><surname>Bailey</surname><given-names>M</given-names></name></person-group><article-title>Association between a chloride-liberal vs chloride-restrictive
intravenous fluid administration strategy and kidney injury in critically
ill adults</article-title><source>JAMA</source><year>2012</year><volume>308</volume><issue>15</issue><fpage>1566</fpage><lpage>1572</lpage><pub-id pub-id-type="pmid">23073953</pub-id></element-citation></ref><ref id="r51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>AD</given-names></name><name><surname>Schermer</surname><given-names>CR</given-names></name><name><surname>Lobo</surname><given-names>DN</given-names></name><name><surname>Munson</surname><given-names>SH</given-names></name><name><surname>Khangulov</surname><given-names>V</given-names></name><name><surname>Hayashida</surname><given-names>DK</given-names></name><etal/></person-group><article-title>Impact of intravenous fluid composition on outcomes in patients
with systemic inflammatory response syndrome</article-title><source>Crit Care</source><year>2015</year><volume>19</volume><fpage>334</fpage><lpage>334</lpage><comment>Erratum in Crit Care. 2016;20:17</comment><pub-id pub-id-type="pmid">26370823</pub-id></element-citation></ref><ref id="r52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donner</surname><given-names>A</given-names></name></person-group><article-title>Some aspects of the design and analysis of cluster randomization
trials</article-title><source>J R Stat Soc Ser C Appl Stat</source><year>1998</year><volume>47</volume><issue>1</issue><fpage>95</fpage><lpage>113</lpage></element-citation></ref><ref id="r53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krajewski</surname><given-names>ML</given-names></name><name><surname>Raghunathan</surname><given-names>K</given-names></name><name><surname>Paluszkiewicz</surname><given-names>SM</given-names></name><name><surname>Schermer</surname><given-names>CR</given-names></name><name><surname>Shaw</surname><given-names>AD</given-names></name></person-group><article-title>Meta-analysis of high- versus low-chloride content in
perioperative and critical care fluid resuscitation</article-title><source>Br J Surg</source><year>2015</year><volume>102</volume><issue>1</issue><fpage>24</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">25357011</pub-id></element-citation></ref></ref-list></back></article>